MPM BioImpact LLC Diversified Active

CIK: 0001687078 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value ($000): $496,603 (100.0% shares, 0.0% debt)

Holdings (34)

CGEM Cullinan Oncology, Inc. 16.6%
Value ($000) $82,295 Shares 7,648,268 Est. Cost $40.60 Unrealized -73.8%
Iveric Bio Inc 9.6%
Value ($000) $47,785 Shares 1,214,662 Est. Cost $20.92 Unrealized
Chinook Therapeutics, Inc. 7.8%
Value ($000) $38,551 Shares 1,003,406 Est. Cost $35.65 Unrealized
GERN Geron Corporation 5.9%
Value ($000) $29,504 Shares 9,191,290 Est. Cost $1.47 Unrealized +93.4%
Reata Pharmaceuticals, Inc. 4.8%
Value ($000) $23,907 Shares 234,478 Est. Cost $50.07 Unrealized
iTeos Therapeutics, Inc. 4.7%
Value ($000) $23,116 Shares 1,745,943 Est. Cost $24.67 Unrealized
NTLA Intellia Therapeutics, Inc. 4.5%
Value ($000) $22,210 Shares 544,639 Est. Cost $77.45 Unrealized -47.6%
IOVA Iovance Biotherapeutics Inc 4.2%
Value ($000) $20,769 Shares 2,950,118 Est. Cost $10.38 Unrealized -31.0%
Repare Therapeutics, Inc. 3.5%
Value ($000) $17,350 Shares 1,639,849 Est. Cost $31.02 Unrealized
RLAY Relay Therapeutics Inc. 3.4%
Value ($000) $17,011 Shares 1,354,368 Est. Cost $17.41 Unrealized -28.6%
Verve Therapeutics, Inc 3.2%
Value ($000) $16,086 Shares 857,940 Est. Cost $30.36 Unrealized
MLTX Moonlake Immunotherapeutics 3.0%
Value ($000) $15,051 Shares 295,111 Est. Cost $26.91 Unrealized 0.0%
RGNX REGENXBIO Inc. 2.6%
Value ($000) $13,128 Shares 656,718 Est. Cost $29.05 Unrealized -33.7%
Karuna Therapeutics Inc 2.3%
Value ($000) $11,580 Shares 53,399 Est. Cost $216.85 Unrealized
INSM Insmed Incorporated 2.3%
Value ($000) $11,178 Shares 529,743 Est. Cost $19.24 Unrealized -1.4%
XERS Xeris Biopharma Holdings Inc 2.1%
Value ($000) $10,414 Shares 3,974,999 Est. Cost $2.55 Unrealized 0.0%
MDGL Madrigal Pharmaceuticals inc 1.8%
Value ($000) $8,781 Shares 38,011 Est. Cost $132.25 Unrealized +104.8%
CRNX Crinetics Pharmaceuticals Inc. 1.7%
Value ($000) $8,633 Shares 479,053 Est. Cost $21.22 Unrealized -6.0%
TVTX Travere Therapeutics Inc. 1.7%
Value ($000) $8,492 Shares 552,846 Est. Cost $18.49 Unrealized -1.6%
RVMD Revolution Medicines, Inc. 1.5%
Value ($000) $7,314 Shares 273,408 Est. Cost $26.97 Unrealized -9.0%
HOWL Werewolf Therapeutics, Inc. 1.5%
Value ($000) $7,283 Shares 2,388,011 Est. Cost $13.70 Unrealized -79.4%
KALV Kalvista Pharmaceuticals Inc 1.4%
Value ($000) $6,854 Shares 761,538 Est. Cost $9.22 Unrealized 0.0%
AXSM Axsome Therapeutics, Inc. 1.4%
Value ($000) $6,725 Shares 93,586 Est. Cost $64.41 Unrealized +14.5%
FOLD Amicus Therapeutics Inc. 1.3%
Value ($000) $6,483 Shares 516,139 Est. Cost $10.65 Unrealized +11.4%
Avadel Pharmaceuticals PLC 1.3%
Value ($000) $6,345 Shares 384,990 Est. Cost $16.48 Unrealized
VRDN Viridian Therapeutics Inc 1.2%
Value ($000) $6,074 Shares 255,323 Est. Cost $25.65 Unrealized 0.0%
EWTX Edgewise Therapeutics Inc 1.1%
Value ($000) $5,524 Shares 712,798 Est. Cost $8.43 Unrealized 0.0%
ADAPY Adaptimmune Therapeutics plc 0.9%
Value ($000) $4,714 Shares 5,095,912 Est. Cost $0.93 Unrealized
OLMA Olema Pharmaceuticals, Inc. 0.8%
Value ($000) $4,176 Shares 462,500 Est. Cost $6.04 Unrealized 0.0%
PHAT Phathom Pharmaceuticals inc 0.8%
Value ($000) $4,043 Shares 282,332 Est. Cost $14.52 Unrealized -20.6%
Harpoon Therapeutics, Inc. 0.5%
Value ($000) $2,270 Shares 3,196,707 Est. Cost $14.79 Unrealized
Inozyme Pharma Inc. 0.4%
Value ($000) $1,821 Shares 326,921 Est. Cost $7.14 Unrealized
VTYX Ventyx Biosciences Inc 0.2%
Value ($000) $1,041 Shares 31,747 Est. Cost $34.47 Unrealized 0.0%
Oncorus, Inc. 0.0%
Value ($000) $96 Shares 2,377,031 Est. Cost $32.33 Unrealized